Skip to content

13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC

SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-10-28, with 79 holding rows worth $295,642,000.

Accession
0001420506-22-001926
Filed
2022-10-28
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 79 entries on the cover page, a total value of $295,642,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $295,642,000 with VALUE read as thousands by filing date, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BELLUS HEALTH INC NEW07987C204COM1,655,775$17,485,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK393,000$14,549,000thousands by filing dateput
PROMETHEUS BIOSCIENCES INC74349U108COM204,700$12,079,000thousands by filing dateput
VERACYTE INC COM92337F107Stock665,854$11,053,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM300,000$10,215,000thousands by filing date
ANAVEX LIFE SCIENCES CORP032797300COM NEW942,500$9,727,000thousands by filing dateput
MORPHIC HLDG INC61775R105COM324,421$9,181,000thousands by filing date
COGENT BIOSCIENCES INC19240Q201COM606,608$9,051,000thousands by filing date
POSEIDA THERAPEUTICS INC73730P108COM2,554,277$9,017,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock245,992$8,880,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock543,776$8,559,000thousands by filing date
Viewra, Inc92672L107COM2,324,066$8,460,000thousands by filing date
IVERIC BIO INC46583P102COM443,100$7,949,000thousands by filing dateput
Mersana Therapeutics Inc59045L106Common Stock994,073$6,720,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock110,000$6,669,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock32,545$6,514,000thousands by filing date
Veru Inc92536C103Common Stock550,000$6,336,000thousands by filing dateput
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK136,126$6,334,000thousands by filing date
APOLLO ENDOSURGERY INC03767D108COM1,136,206$6,260,000thousands by filing date
MERUS N VN5749R100COM295,136$5,912,000thousands by filing date
CERUS CORP157085101COM1,616,459$5,819,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM983,516$5,724,000thousands by filing date
CLENE INC185634102COM1,734,800$4,857,000thousands by filing dateput
INSMED INC COM PAR $.01457669307Stock224,016$4,825,000thousands by filing date
NKARTA INC65487U108COMMON STOCK362,377$4,769,000thousands by filing date
PLIANT THERAPEUTICS INC729139105COM209,822$4,383,000thousands by filing date
ACUMEN PHARMACEUTICALS INC00509G209CMN420,000$4,213,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock56,645$3,948,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM1,208,992$3,869,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM11,105$3,215,000thousands by filing date
IVERIC BIO INC46583P102COM177,364$3,182,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM42,500$2,968,000thousands by filing datecall
CRINETICS PHARMACEUTICALS INC COM22663K107Stock149,027$2,927,000thousands by filing date
REGENXBIO INC75901B107COM110,085$2,910,000thousands by filing date
CULLINAN THERAPEUTICS INC230031106COM224,555$2,879,000thousands by filing date
CVRX INC126638105COMMON STOCK307,920$2,873,000thousands by filing date
LAVA THERAPEUTICS NVN51517105SHS610,809$2,791,000thousands by filing date
ALLAKOS INC01671P100COM400,000$2,448,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM366,493$2,353,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock186,603$2,351,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM10,323$2,322,000thousands by filing date
POINT BIOPHARMA GLOBAL INC730541109COM300,000$2,319,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock10,696$2,240,000thousands by filing date
PHREESIA INC71944F106COM83,305$2,123,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock314,095$2,104,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK438,695$2,097,000thousands by filing date
ARVINAS INC04335A105COM40,741$1,813,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM32,011$1,791,000thousands by filing date
IMMUNOVANT INC45258J102COM300,000$1,674,000thousands by filing date
IMMATICS N.VN44445109SHS163,938$1,639,000thousands by filing date
BIOATLA INC09077B104COM200,422$1,543,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW53,275$1,498,000thousands by filing date
SEAGEN INC81181C104COM10,627$1,454,000thousands by filing date
89BIO INC282559103COM250,000$1,448,000thousands by filing date
TREVI THERAPEUTICS INC COM89532M101Stock939,265$1,446,000thousands by filing date
AMRYT PHARMA LTD - SPNR ADR03217L106COMMON EQUITY188,300$1,303,000thousands by filing date
CLIMB BIO INC28658R106COMMON STOCK402,088$1,299,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW100,469$1,283,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM94,517$1,236,000thousands by filing date
ANAVEX LIFE SCIENCES CORP032797300COM NEW100,000$1,032,000thousands by filing datecall
CODEXIS INC192005106COM145,437$881,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock108,285$857,000thousands by filing date
NUVALENT INC COM670703107Stock41,439$806,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM10,220$714,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS10,131$627,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK346,231$623,000thousands by filing date
COMPASS THERAPEUTICS INC20454B104COM262,090$598,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR5,000$516,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK55,342$465,000thousands by filing date
MACROGENICS INC556099109COM100,000$346,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock5,000$303,000thousands by filing dateput
NUCANA PLC67022C106ADR269,682$282,000thousands by filing date
PRAXIS PRECISION MEDICINES I74006W108COM100,000$227,000thousands by filing date
ELOXX PHARMACEUTICALS INC29014R103COM1,098,469$187,000thousands by filing date
EVOGENE LTDM4119S104SHS167,510$139,000thousands by filing date
TERNS PHARMACEUTICALS INC COM880881107Stock14,473$85,000thousands by filing date
POLYPID LTDM8001Q118SHS50,000$59,000thousands by filing dateput
Renovacor Inc75989E114Warrant104,828$8,000thousands by filing date
MEDICUS SCIENCES ACQUISITIONG5960S124*W EXP 02/12/20249,990$1,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-22-001926this filing2022-10-28acceptance time not in the bulk data set